Report

1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.3 STUDY SCOPE 31
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 31
1.3.2 YEARS CONSIDERED 32
1.3.3 INCLUSIONS AND EXCLUSIONS 32
1.4 CURRENCY CONSIDERED 33
1.5 UNIT CONSIDERED 33
1.6 LIMITATIONS 34
1.7 STAKEHOLDERS 34
1.8 SUMMARY OF CHANGES 34
2 EXECUTIVE SUMMARY 35
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 35
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 36
2.3 DISRUPTIVE TRENDS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 37
2.4 HIGH-GROWTH SEGMENTS 38
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 39
3 PREMIUM INSIGHTS 40
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 40
3.2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 41
3.3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE 41
3.4 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY 42
3.5 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA,
BY EQUIPMENT TYPE AND COUNTRY 42
3.6 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY GEOGRAPHY 43
4 MARKET OVERVIEW 44
4.1 INTRODUCTION 44
4.2 MARKET DYNAMICS 44
4.2.1 DRIVERS 45
4.2.1.1 Increasing commercialization of biologics and complex formulations 45
4.2.1.2 Growing preference for personalized medicines and targeted therapies 45
4.2.1.3 Rapid advances in automation, digital monitoring, and Industry 4.0 technologies 46
4.2.1.4 Escalating generic drug production 46
4.2.2 RESTRAINTS 47
4.2.2.1 High capital expenditure requirements 47
4.2.2.2 Issues related to integration with existing systems 48
4.2.2.3 Implementation of stringent regulatory compliance standards 48
4.2.3 OPPORTUNITIES 49
4.2.3.1 Expansion of contract development and manufacturing organizations 49
4.2.3.2 Mounting demand for sterile and aseptic injectable drugs 50
4.2.3.3 Rising deployment of advanced inspection and serialization technologies 50
4.2.4 CHALLENGES 51
4.2.4.1 Requirement for frequent technological upgrades 51
4.2.4.2 Complex validation and revalidation cycles 52
4.2.4.3 Technical and operational challenges related to small-batch production 52
4.3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 53
4.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 55
5 INDUSTRY TRENDS 57
5.1 PORTER'S FIVE FORCES ANALYSIS 57
5.1.1 BARGAINING POWER OF SUPPLIERS 58
5.1.2 BARGAINING POWER OF BUYERS 59
5.1.3 THREAT OF NEW ENTRANTS 59
5.1.4 THREAT OF SUBSTITUTES 59
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 59
5.2 MACROECONOMIC OUTLOOK 60
5.2.1 INTRODUCTION 60
5.2.2 GDP TRENDS AND FORECAST 60
5.2.3 TRENDS IN GLOBAL BIOPHARMACEUTICAL & VACCINE MANUFACTURING INDUSTRY 62
5.2.4 TRENDS IN GLOBAL GENERIC DRUG & ORAL SOLID DOSAGE MANUFACTURING INDUSTRY 62
5.3 VALUE CHAIN ANALYSIS 63
5.4 ECOSYSTEM ANALYSIS 66
5.5 PRICING ANALYSIS 68
5.5.1 PRICING RANGE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT OFFERED BY KEY PLAYERS, BY EQUIPMENT TYPE, 2025 68
5.5.2 AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, 2022-2025 69
5.5.3 AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES,
BY REGION, 2022-2025 70
5.6 INVESTMENT AND FUNDING SCENARIO 71
5.7 TRADE ANALYSIS 72
5.7.1 IMPORT SCENARIO (HS CODE 8479) 72
5.7.2 EXPORT SCENARIO (HS CODE 8479) 73
?
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 74
5.9 KEY CONFERENCES AND EVENTS, 2026 75
5.10 CASE STUDY ANALYSIS 75
5.10.1 INOXPA STRENGTHENS AVVA PHARMACEUTICALS' MANUFACTURING CAPABILITIES THROUGH MODULAR PHARMACEUTICAL PROCESSING SYSTEM 75
5.10.2 GEA GROUP INSTALLS PSD-3 PHARMACEUTICAL SPRAY DRYER AT CHUGAI PHARMACEUTICAL'S FJ3 FACILITY TO PROCESS PHARMACEUTICAL COMPOUNDS 76
5.10.3 ZAMBON COMPANY AND IMA ACTIVE COLLABORATE ON PROCESS OPTIMIZATION PROJECT TO ENHANCE BATCH CONSISTENCY AND QUALITY 77
5.10.4 ACG HELPS INDIAN PHARMACEUTICAL COMPANY RETROFIT B MAX MACHINE WITH NITROGEN-ENHANCED PURGING SYSTEM TO IMPROVE STABILITY AND SHELF LIFE 78
5.10.5 SYNTEGON PROVIDES AIM 5022S PLATFORM TO JIANGSU JINDIKE PHARMACEUTICAL TO ENHANCE INSPECTION EFFICIENCY AND ACCURACY 79
5.11 IMPACT OF 2025 US TARIFF - PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 80
5.11.1 INTRODUCTION 80
5.11.2 KEY TARIFF RATES 81
5.11.3 PRICE IMPACT ANALYSIS 81
5.11.4 IMPACT ON COUNTRIES/REGIONS 82
5.11.4.1 US 82
5.11.4.2 Europe 83
5.11.4.3 Asia Pacific 84
5.11.5 IMPACT ON EQUIPMENT TYPES 85
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACTS,
PATENTS, AND INNOVATIONS 87
6.1 KEY TECHNOLOGIES 87
6.1.1 CONTINUOUS MANUFACTURING 87
6.1.2 DIGITAL TWIN 87
6.1.3 STERILE AND ASEPTIC PROCESSING 87
6.1.4 SOLID DOSAGE MANUFACTURING 88
6.1.5 AUTOMATION AND ROBOTICS 88
6.1.6 INTERNET OF THINGS (IOT) AND SMART SENSORS 88
6.2 ADJACENT TECHNOLOGIES 89
6.2.1 COMPUTER-AIDED DESIGN (CAD) AND COMPUTER-AIDED MANUFACTURING (CAM) 89
6.2.2 ADVANCED CNC MACHINING AND PRECISION MANUFACTURING 89
6.3 COMPLEMENTARY TECHNOLOGIES 90
6.3.1 3D PRINTING 90
6.3.2 INDUSTRIAL AUTOMATION SYSTEMS 90
6.4 TECHNOLOGY ROADMAP 90
6.5 PATENT ANALYSIS 93
6.6 IMPACT OF AI ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 95
6.6.1 TOP USE CASES AND MARKET POTENTIAL 96
6.6.2 BEST PRACTICES FOLLOWED BY OEMS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 96
6.6.3 CASE STUDIES RELATED TO AI IMPLEMENTATION IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 97
6.6.4 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS 98
6.6.5 CLIENTS' READINESS TO ADOPT AI-INTEGRATED PHARMACEUTICAL MANUFACTURING EQUIPMENT 98
7 REGULATORY LANDSCAPE 99
7.1 REGIONAL REGULATIONS AND COMPLIANCE 99
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
7.1.2 INDUSTRY STANDARDS 101
7.1.3 REGULATIONS 102
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 104
8.1 DECISION-MAKING PROCESS 104
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND EVALUATION CRITERIA 106
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 106
8.2.2 BUYING CRITERIA 107
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 107
8.4 UNMET NEEDS OF EQUIPMENT TYPES 109
9 END USERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT 111
9.1 INTRODUCTION 111
9.2 PHARMACEUTICAL MANUFACTURING COMPANIES 111
9.3 CONTRACT MANUFACTURING ORGANIZATIONS 112
10 MANUFACTURING PROCESSES OF PHARMACEUTICAL EQUIPMENT 113
10.1 INTRODUCTION 113
10.2 FORMULATION PROCESS 113
10.3 TABLETING & ENCAPSULATION PROCESS 114
10.4 ASEPTIC PROCESS 114
10.5 PACKAGING PROCESS 115
10.6 QUALITY CONTROL PROCESS 115
11 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE 116
11.1 INTRODUCTION 117
11.2 PACKAGING MACHINES 120
11.2.1 INCREASING PRODUCT AND STOCK KEEPING UNIT PROLIFERATION TO BOOST SEGMENTAL GROWTH 120
11.3 FILLING MACHINES 125
11.3.1 RISING STERILE AND ASEPTIC MANUFACTURING TO CONTRIBUTE
TO SEGMENTAL GROWTH 125
11.4 SPRAY DRYING EQUIPMENT 130
11.4.1 ESCALATING NUMBER OF POORLY SOLUBLE DRUG MOLECULES
TO FOSTER SEGMENTAL GROWTH 130
11.5 MIXING & BLENDING MACHINES 135
11.5.1 MOUNTING CONSUMPTION OF SOLID ORAL DOSAGE FORMS
TO BOLSTER SEGMENTAL GROWTH 135
11.6 MILLING EQUIPMENT 139
11.6.1 RISING NEED FOR TIGHT PARTICLE SIZE CONTROL TO ACCELERATE SEGMENTAL GROWTH 139
11.7 EXTRUSION EQUIPMENT 144
11.7.1 GROWING EMPHASIS ON IMPROVING BIOAVAILABILITY OF POORLY
SOLUBLE DRUGS TO SPUR DEMAND 144
11.8 TABLET COMPRESSION PRESSES 148
11.8.1 LARGE-SCALE PRODUCTION OF TABLETS AND HIGH-VOLUME PRODUCTION REQUIREMENTS TO FUEL SEGMENTAL GROWTH 148
11.9 INSPECTION EQUIPMENT 153
11.9.1 HEIGHTENED FOCUS ON QUALITY ASSURANCE AND RISK REDUCTION TO EXPEDITE SEGMENTAL GROWTH 153
11.10 GRANULATION EQUIPMENT 159
11.10.1 REQUIREMENT FOR CONSISTENT AND REPRODUCIBLE MANUFACTURING PROCESSES TO BOOST SEGMENTAL GROWTH 159
11.11 STERILIZATION EQUIPMENT 163
11.11.1 INCREASING PRODUCTION OF STERILE DRUGS AND REGULATORY SCRUTINY TO FOSTER SEGMENTAL GROWTH 163
12 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY END-PRODUCT TYPE 168
12.1 INTRODUCTION 169
12.2 SOLID 170
12.2.1 STABILITY, EASE OF STORAGE AND TRANSPORT, AND LOW MANUFACTURING COSTS TO AUGMENT SEGMENTAL GROWTH 170
12.3 LIQUID 171
12.3.1 HIGH PREFERENCE FOR BIOLOGICS, VACCINES, AND INJECTABLE THERAPIES TO EXPEDITE SEGMENTAL GROWTH 171
13 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY 172
13.1 INTRODUCTION 173
13.2 SEMI-AUTOMATIC 174
13.2.1 MOUNTING DEMAND FOR SMALL-SCALE AND FLEXIBLE PHARMACEUTICAL MANUFACTURING TO FUEL SEGMENTAL GROWTH 174
?
13.3 AUTOMATIC 175
13.3.1 RISING NEED FOR HIGH PRODUCTIVITY AND STRINGENT REGULATORY REQUIREMENTS TO AUGMENT SEGMENTAL GROWTH 175
14 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION 176
14.1 INTRODUCTION 177
14.2 NORTH AMERICA 178
14.2.1 US 181
14.2.1.1 Increasing investment in compliance-ready equipment to strengthen healthcare production capabilities to drive market 181
14.2.2 CANADA 183
14.2.2.1 Mounting adoption of automation and regulatory frameworks to foster market growth 183
14.2.3 MEXICO 185
14.2.3.1 Rising domestic track-and-trace requirements and export compliance to support market growth 185
14.3 EUROPE 187
14.3.1 UK 190
14.3.1.1 Government support for life sciences sector and strong regulatory standards to boost market growth 190
14.3.2 GERMANY 192
14.3.2.1 Strong engineering capabilities, advanced automation, and early adoption of digital manufacturing practices to drive market 192
14.3.3 FRANCE 193
14.3.3.1 High investment in validated manufacturing, filling, inspection, and packaging equipment to fuel market growth 193
14.3.4 ITALY 195
14.3.4.1 Growing focus on sterile and high-value manufacturing to contribute to market growth 195
14.3.5 REST OF EUROPE 196
14.4 ASIA PACIFIC 198
14.4.1 CHINA 201
14.4.1.1 Rising emphasis on innovative drug development and automated manufacturing technologies to expedite market growth 201
14.4.2 JAPAN 203
14.4.2.1 Strong focus on manufacturing process control, accuracy, and reliability to accelerate market growth 203
14.4.3 INDIA 205
14.4.3.1 Large-scale generic drug manufacturing base to drive market 205
14.4.4 SOUTH KOREA 206
14.4.4.1 Advanced technological capabilities and strong regulatory framework to foster market growth 206
14.4.5 REST OF ASIA PACIFIC 208
?
14.5 ROW 210
14.5.1 MIDDLE EAST & AFRICA 212
14.5.1.1 GCC 215
14.5.1.1.1 Rising adoption of healthcare localization and economic diversification strategies to bolster market growth 215
14.5.1.2 South Africa 215
14.5.1.2.1 Increasing vaccine and biologics manufacturing capabilities to augment market growth 215
14.5.1.3 Rest of Middle East & Africa 216
14.5.2 SOUTH AMERICA 216
14.5.2.1 Brazil 218
14.5.2.1.1 Strong focus on compliance with track-and-trace regulations to contribute to market growth 218
14.5.2.2 Argentina 219
14.5.2.2.1 Mounting demand for tablet compression, capsule filling, granulation, and coating equipment to support market growth 219
14.5.2.3 Rest of South America 219
15 COMPETITIVE LANDSCAPE 221
15.1 OVERVIEW 221
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2026 221
15.3 REVENUE ANALYSIS, 2021-2025 224
15.4 MARKET SHARE ANALYSIS, 2O25 224
15.5 COMPANY VALUATION AND FINANCIAL METRICS 227
15.6 BRAND COMPARISON 228
15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 228
15.7.1 STARS 228
15.7.2 EMERGING LEADERS 228
15.7.3 PERVASIVE PLAYERS 229
15.7.4 PARTICIPANTS 229
15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 230
15.7.5.1 Company footprint 230
15.7.5.2 Region footprint 231
15.7.5.3 Equipment type footprint 232
15.7.5.4 End-product type footprint 233
15.7.5.5 Technology footprint 234
15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 234
15.8.1 PROGRESSIVE COMPANIES 234
15.8.2 RESPONSIVE COMPANIES 234
15.8.3 DYNAMIC COMPANIES 235
15.8.4 STARTING BLOCKS 235
15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 236
15.8.5.1 Detailed list of key startups/SMEs 236
15.8.5.2 Competitive benchmarking of key startups/SMEs 237
15.9 COMPETITIVE SCENARIO 240
15.9.1 PRODUCT LAUNCHES 240
15.9.2 DEALS 243
15.9.3 EXPANSIONS 249
16 COMPANY PROFILES 251
16.1 KEY PLAYERS 251
16.1.1 GEA GROUP AKTIENGESELLSCHAFT 251
16.1.1.1 Business overview 251
16.1.1.2 Products/Solutions/Services offered 252
16.1.1.3 Recent developments 253
16.1.1.3.1 Product launches 253
16.1.1.3.2 Deals 254
16.1.1.4 MnM view 254
16.1.1.4.1 Key strengths/Right to win 254
16.1.1.4.2 Strategic choices 254
16.1.1.4.3 Weaknesses/Competitive threats 254
16.1.2 KORBER AG 255
16.1.2.1 Business overview 255
16.1.2.2 Products/Solutions/Services offered 255
16.1.2.3 Recent developments 256
16.1.2.3.1 Deals 256
16.1.2.3.2 Expansions 258
16.1.2.4 MnM view 258
16.1.2.4.1 Key strengths/Right to win 258
16.1.2.4.2 Strategic choices 258
16.1.2.4.3 Weaknesses/Competitive threats 259
16.1.3 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA 260
16.1.3.1 Business overview 260
16.1.3.2 Products/Solutions/Services offered 261
16.1.3.3 Recent developments 261
16.1.3.3.1 Product launches 261
16.1.3.3.2 Deals 261
16.1.3.4 MnM view 262
16.1.3.4.1 Key strengths/Right to win 262
16.1.3.4.2 Strategic choices 262
16.1.3.4.3 Weaknesses/Competitive threats 263
16.1.4 SYNTEGON TECHNOLOGY GMBH 264
16.1.4.1 Business overview 264
16.1.4.2 Products/Solutions/Services offered 264
16.1.4.3 Recent developments 265
16.1.4.3.1 Product launches 265
16.1.4.3.2 Deals 266
16.1.4.3.3 Expansions 267
16.1.4.4 MnM view 267
16.1.4.4.1 Key strengths/Right to win 267
16.1.4.4.2 Strategic choices 267
16.1.4.4.3 Weaknesses/Competitive threats 267
16.1.5 ACG 268
16.1.5.1 Business overview 268
16.1.5.2 Products/Solutions/Services offered 268
16.1.5.3 Recent developments 269
16.1.5.3.1 Deals 269
16.1.5.3.2 Expansions 269
16.1.5.4 MnM view 269
16.1.5.4.1 Key strengths/Right to win 269
16.1.5.4.2 Strategic choices 270
16.1.5.4.3 Weaknesses/Competitive threats 270
16.1.6 THERMO FISHER SCIENTIFIC INC. 271
16.1.6.1 Business overview 271
16.1.6.2 Products/Solutions/Services offered 272
16.1.6.3 Recent developments 273
16.1.6.3.1 Deals 273
16.1.6.3.2 Expansions 274
16.1.7 ROMACO GROUP 275
16.1.7.1 Business overview 275
16.1.7.2 Products/Solutions/Services offered 275
16.1.7.3 Recent developments 276
16.1.7.3.1 Product launches 276
16.1.7.3.2 Deals 277
16.1.8 MARCHESINI GROUP S.P.A. 278
16.1.8.1 Business overview 278
16.1.8.2 Products/Solutions/Services offered 278
16.1.8.3 Recent developments 279
16.1.8.3.1 Product launches 279
16.1.8.3.2 Deals 279
16.1.9 MG2 S.R.L. 281
16.1.9.1 Business overview 281
16.1.9.2 Products/Solutions/Services offered 281
16.1.9.3 Recent developments 282
16.1.9.3.1 Product launches 282
?
16.1.10 GLATT GMBH 283
16.1.10.1 Business overview 283
16.1.10.2 Products/Solutions/Services offered 283
16.2 OTHER PLAYERS 284
16.2.1 BAUSCH+STROBEL SE + CO. KG 284
16.2.2 COPERION GMBH 285
16.2.3 ELIZABETH COMPANIES 286
16.2.4 FETTE COMPACTING 287
16.2.5 FREUND 288
16.2.6 KORSCH AG 289
16.2.7 L.B. BOHLE MASCHINEN UND VERFAHREN GMBH 290
16.2.8 LFA MACHINES 291
16.2.9 CVC TECHNOLOGIES, INC. 292
16.2.10 OHARA TECHNOLOGIES 293
16.2.11 PRISM PHARMA MACHINERY 294
16.2.12 SAINTYCO 295
16.2.13 SILVERSON 296
16.2.14 YENCHEN MACHINERY CO., LTD. 297
16.2.15 QUALICAPS 298
16.2.16 COESIA S.P.A. 299
16.2.17 UHLMANN 300
16.2.18 AST, LLC 301
17 RESEARCH METHODOLOGY 302
17.1 RESEARCH DATA 302
17.1.1 SECONDARY AND PRIMARY RESEARCH 303
17.1.2 SECONDARY DATA 304
17.1.2.1 List of key secondary sources 304
17.1.2.2 Key data from secondary sources 304
17.1.3 PRIMARY DATA 305
17.1.3.1 List of primary interview participants 305
17.1.3.2 Key data from primary sources 306
17.1.3.3 Key industry insights 306
17.1.3.4 Breakdown of primaries 307
17.2 MARKET SIZE ESTIMATION 307
17.2.1 BOTTOM-UP APPROACH 307
17.2.2 TOP-DOWN APPROACH 308
17.2.3 MARKET SIZE CALCULATION FOR BASE YEAR 309
17.3 MARKET FORECAST APPROACH 309
17.3.1 SUPPLY SIDE 309
17.3.2 DEMAND SIDE 309
?
17.4 FACTOR ANALYSIS 310
17.5 DATA TRIANGULATION 311
17.6 RESEARCH ASSUMPTIONS 312
17.7 RESEARCH LIMITATIONS 312
17.8 RISK ANALYSIS 313
18 APPENDIX 314
18.1 INSIGHTS FROM INDUSTRY EXPERTS 314
18.2 DISCUSSION GUIDE 315
18.3 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 318
18.4 CUSTOMIZATION OPTIONS 320
18.5 RELATED REPORTS 320
18.6 AUTHOR DETAILS 321

TABLE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
INCLUSIONS AND EXCLUSIONS 32
TABLE 2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
SUMMARY OF CHANGES 34
TABLE 3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 54
TABLE 4 STRATEGIC FOCUS OF MAJOR COMPANIES IN PHARMACEUTICAL
MANUFACTURING EQUIPMENT MARKET 55
TABLE 5 IMPACT OF PORTER'S FIVE FORCES 57
TABLE 6 GDP GROWTH RATES, BY COUNTRY, 2021-2030 (%) 60
TABLE 7 ROLE OF COMPANIES IN PHARMACEUTICAL MANUFACTURING
EQUIPMENT ECOSYSTEM 67
TABLE 8 PRICING RANGE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT
PROVIDED BY KEY PLAYERS, BY EQUIPMENT TYPE, 2025 (USD) 68
TABLE 9 AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, 2022-2025 (USD) 69
TABLE 10 AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, BY REGION,
2022-2025 (USD) 70
TABLE 11 IMPORT DATA FOR HS CODE 8479-COMPLIANT PRODUCTS, BY COUNTRY,
2021-2025 (USD MILLION) 72
TABLE 12 EXPORT DATA FOR HS CODE 8479-COMPLIANT PRODUCTS, BY COUNTRY,
2021-2025 (USD MILLION) 73
TABLE 13 LIST OF KEY CONFERENCES AND EVENTS, 2026 75
TABLE 14 INOXPA IMPLEMENTS MODULAR PHARMACEUTICAL PROCESSING SYSTEM TO STRENGTHEN AVVA PHARMACEUTICALS' MANUFACTURING CAPABILITIES 75
TABLE 15 GEA SUPPLIES PSD-3 PHARMACEUTICAL SPRAY DRYER TO HELP CHUGAI PHARMACEUTICAL PROCESS PHARMACEUTICAL COMPOUNDS 76
TABLE 16 ZAMBON COMPANY UNITES WITH IMA ACTIVE ON PROCESS OPTIMIZATION PROJECT TO SUPPORT PRODUCTION CAPACITY AND MAINTAIN OPERATIONAL EFFICIENCY 77
TABLE 17 ACG DEVELOPS RETROFIT SOLUTION TO INCREASE STABILITY AND SHELF LIFE OF INDIAN PHARMACEUTICAL COMPANY 78
TABLE 18 SYNTEGON'S AIM 5022S PLATFORM HELPS JIANGSU JINDIKE PHARMACEUTICAL ENHANCE INSPECTION EFFICIENCY AND ACCURACY OF PRE-FILLED SYRINGES 79
TABLE 19 US-ADJUSTED RECIPROCAL TARIFF RATES 81
TABLE 20 TECHNOLOGY ROADMAP IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 91
TABLE 21 LIST OF KEY PATENTS, 2023-2025 94
TABLE 22 TOP USE CASES AND MARKET POTENTIAL 96
TABLE 23 BEST PRACTICES FOLLOWED BY COMPANIES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 96
TABLE 24 CASE STUDIES ON AI IMPLEMENTATION IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 97
TABLE 25 INTERCONNECTED ECOSYSTEM AND IMPACT ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET PLAYERS 98
TABLE 26 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 99
TABLE 27 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 100
TABLE 28 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 100
TABLE 29 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 101
TABLE 30 PHARMACEUTICAL MANUFACTURING EQUIPMENT INDUSTRY STANDARDS 101
TABLE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-PRODUCT TYPE (%) 106
TABLE 32 KEY BUYING CRITERIA FOR END-PRODUCT TYPES 107
TABLE 33 UNMET NEEDS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE 109
TABLE 34 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 118
TABLE 35 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 118
TABLE 36 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (THOUSAND UNITS) 119
TABLE 37 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (THOUSAND UNITS) 119
TABLE 38 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION) 121
TABLE 39 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION) 121
TABLE 40 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION) 121
TABLE 41 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION) 122
TABLE 42 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION) 122
TABLE 43 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION) 122
TABLE 44 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION) 123
TABLE 45 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION) 123
TABLE 46 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION) 123
TABLE 47 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION) 124
TABLE 48 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION) 124
TABLE 49 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION) 124
TABLE 50 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY REGION, 2021-2025 (USD MILLION) 126
TABLE 51 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY REGION, 2026-2032 (USD MILLION) 126
TABLE 52 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION) 126
TABLE 53 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION) 127
TABLE 54 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION) 127
TABLE 55 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION) 127
TABLE 56 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION) 128
TABLE 57 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION) 128
TABLE 58 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN ROW, BY REGION, 2021-2025 (USD MILLION) 128
TABLE 59 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN ROW, BY REGION, 2026-2032 (USD MILLION) 129
TABLE 60 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY END-PRODUCT TYPE, 2021-2025 (USD MILLION) 129
TABLE 61 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY END-PRODUCT TYPE, 2026-2032 (USD MILLION) 129
TABLE 62 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION) 131
TABLE 63 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION) 131
TABLE 64 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION) 131
TABLE 65 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION) 132
TABLE 66 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION) 132
TABLE 67 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION) 132
TABLE 68 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION) 133
TABLE 69 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION) 133
TABLE 70 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION) 133
TABLE 71 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION) 134
TABLE 72 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION) 134
TABLE 73 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION) 134
TABLE 74 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION) 135
TABLE 75 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION) 135
TABLE 76 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION) 136
TABLE 77 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION) 136
TABLE 78 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION) 136
TABLE 79 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION) 137
TABLE 80 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION) 137
TABLE 81 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION) 138
TABLE 82 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION) 138
TABLE 83 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION) 138
TABLE 84 MIXING & BLENDING: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION) 138
TABLE 85 MIXING & BLENDING: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION) 139
TABLE 86 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION) 139
TABLE 87 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION) 140
TABLE 88 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION) 140
TABLE 89 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION) 140
TABLE 90 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION) 141
TABLE 91 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION) 141
TABLE 92 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION) 142
TABLE 93 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION) 142
TABLE 94 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION) 142
TABLE 95 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION) 143
TABLE 96 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION) 143
TABLE 97 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION) 143
TABLE 98 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION) 144
TABLE 99 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION) 144
TABLE 100 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION) 145
TABLE 101 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION) 145
TABLE 102 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION) 145
TABLE 103 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION) 146
TABLE 104 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION) 146
TABLE 105 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION) 147
TABLE 106 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION) 147
TABLE 107 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION) 147
TABLE 108 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION) 148
TABLE 109 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION) 148
TABLE 110 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION) 149
TABLE 111 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION) 149
TABLE 112 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY,
2021-2025 (USD MILLION) 150
TABLE 113 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY,
2026-2032 (USD MILLION) 150
TABLE 114 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION) 150
TABLE 115 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION) 151
TABLE 116 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION) 151
TABLE 117 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION) 152
TABLE 118 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION) 152
TABLE 119 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION) 152
TABLE 120 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION) 153
TABLE 121 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION) 153
TABLE 122 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION) 154
TABLE 123 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION) 155
TABLE 124 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION) 155
TABLE 125 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION) 155
TABLE 126 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION) 156
TABLE 127 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION) 156
TABLE 128 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION) 157
TABLE 129 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION) 157
TABLE 130 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION) 157
TABLE 131 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION) 158
TABLE 132 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION) 158
TABLE 133 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION) 158
TABLE 134 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION) 159
TABLE 135 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION) 159
TABLE 136 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION) 160
TABLE 137 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION) 160
TABLE 138 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION) 160
TABLE 139 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION) 161
TABLE 140 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION) 161
TABLE 141 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION) 162
TABLE 142 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION) 162
TABLE 143 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION) 162
TABLE 144 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION) 163
TABLE 145 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION) 163
TABLE 146 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION) 164
TABLE 147 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION) 164
TABLE 148 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION) 164
TABLE 149 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION) 165
TABLE 150 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION) 165
TABLE 151 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION) 165
TABLE 152 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION) 166
TABLE 153 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION) 166
TABLE 154 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION) 166
TABLE 155 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION) 167
TABLE 156 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION) 167
TABLE 157 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION) 167
TABLE 158 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION) 170
TABLE 159 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032, (USD MILLION) 170
TABLE 160 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY, 2021-2025 (USD MILLION) 174
TABLE 161 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY, 2026-2032, (USD MILLION) 174
TABLE 162 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION,
2021-2025 (USD MILLION) 177
TABLE 163 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION,
2026-2032 (USD MILLION) 178
TABLE 164 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY COUNTRY, 2021-2025 (USD MILLION) 179
TABLE 165 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY COUNTRY, 2026-2032 (USD MILLION) 180
TABLE 166 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 180
TABLE 167 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 181
TABLE 168 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 182
TABLE 169 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 183
TABLE 170 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 184
TABLE 171 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 185
TABLE 172 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 186
TABLE 173 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 186
TABLE 174 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021-2025 (USD MILLION) 188
TABLE 175 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026-2032 (USD MILLION) 189
TABLE 176 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 189
TABLE 177 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 190
TABLE 178 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 191
TABLE 179 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 191
TABLE 180 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 192
TABLE 181 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 193
TABLE 182 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 194
TABLE 183 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 194
TABLE 184 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 195
TABLE 185 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 196
TABLE 186 REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 197
TABLE 187 REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 197
TABLE 188 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY COUNTRY, 2021-2025 (USD MILLION) 199
TABLE 189 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY COUNTRY, 2026-2032 (USD MILLION) 200
TABLE 190 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 200
TABLE 191 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 201
TABLE 192 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 202
TABLE 193 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 203
TABLE 194 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 204
TABLE 195 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 204
TABLE 196 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 205
TABLE 197 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 206
TABLE 198 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 207
TABLE 199 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 208
TABLE 200 REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 209
TABLE 201 REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 209
TABLE 202 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION) 210
TABLE 203 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION) 211
TABLE 204 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 211
TABLE 205 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 212
TABLE 206 MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021-2025 (USD MILLION) 213
TABLE 207 MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026-2032 (USD MILLION) 213
TABLE 208 MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 214
TABLE 209 MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 214
TABLE 210 SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2021-2025 (USD MILLION) 217
TABLE 211 SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY EQUIPMENT TYPE, 2026-2032 (USD MILLION) 217
TABLE 212 SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY COUNTRY, 2021-2025 (USD MILLION) 218
TABLE 213 SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY COUNTRY, 2026-2032 (USD MILLION) 218
TABLE 214 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2022-JANUARY 2026 221
TABLE 215 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
DEGREE OF COMPETITION, 2025 225
TABLE 216 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: REGION FOOTPRINT 231
TABLE 217 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: EQUIPMENT TYPE FOOTPRINT 232
TABLE 218 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
END-PRODUCT TYPE FOOTPRINT 233
TABLE 219 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
TECHNOLOGY FOOTPRINT 234
TABLE 220 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
DETAILED LIST OF KEY STARTUPS/SMES 236
TABLE 221 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 237
TABLE 222 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
PRODUCT LAUNCHES, JANUARY 2022?JANUARY 2026 240
TABLE 223 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
DEALS, JANUARY 2022?JANUARY 2026 243
TABLE 224 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
EXPANSIONS, JANUARY 2022?JANUARY 2026 249
TABLE 225 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW 251
TABLE 226 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252
TABLE 227 GEA GROUP AKTIENGESELLSCHAFT: PRODUCT LAUNCHES 253
TABLE 228 GEA GROUP AKTIENGESELLSCHAFT: DEALS 254
TABLE 229 KORBER AG: COMPANY OVERVIEW 255
TABLE 230 KORBER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 255
TABLE 231 KORBER AG: DEALS 256
TABLE 232 KORBER AG: EXPANSIONS 258
TABLE 233 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: COMPANY OVERVIEW 260
TABLE 234 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: PRODUCTS/
SOLUTIONS/SERVICES OFFERED 261
TABLE 235 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: PRODUCT LAUNCHES 261
TABLE 236 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: DEALS 261
TABLE 237 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW 264
TABLE 238 SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 264
TABLE 239 SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES 265
TABLE 240 SYNTEGON TECHNOLOGY GMBH: DEALS 266
TABLE 241 SYNTEGON TECHNOLOGY GMBH: EXPANSIONS 267
TABLE 242 ACG: COMPANY OVERVIEW 268
TABLE 243 ACG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 268
TABLE 244 ACG: DEALS 269
TABLE 245 ACG: EXPANSIONS 269
TABLE 246 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 271
TABLE 247 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 272
TABLE 248 THERMO FISHER SCIENTIFIC INC.: DEALS 273
TABLE 249 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS 274
TABLE 250 ROMACO GROUP: COMPANY OVERVIEW 275
TABLE 251 ROMACO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 275
TABLE 252 ROMACO GROUP: PRODUCT LAUNCHES 276
TABLE 253 ROMACO GROUP: DEALS 277
TABLE 254 MARCHESINI GROUP S.P.A.: COMPANY OVERVIEW 278
TABLE 255 MARCHESINI GROUP S.P.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 278
TABLE 256 MARCHESINI GROUP S.P.A.: PRODUCT LAUNCHES 279
TABLE 257 MARCHESINI GROUP S.P.A.: DEALS 279
TABLE 258 MG2 S.R.L.: COMPANY OVERVIEW 281
TABLE 259 MG2 S.R.L.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 281
TABLE 260 MG2 S.R.L.: PRODUCT LAUNCHES 282
TABLE 261 GLATT GMBH: COMPANY OVERVIEW 283
TABLE 262 GLATT GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 283
TABLE 263 BAUSCH+STROBEL SE + CO. KG: COMPANY OVERVIEW 284
TABLE 264 COPERION GMBH: COMPANY OVERVIEW 285
TABLE 265 ELIZABETH COMPANIES: COMPANY OVERVIEW 286
TABLE 266 FETTE COMPACTING: COMPANY OVERVIEW 287
TABLE 267 FREUND: COMPANY OVERVIEW 288
TABLE 268 KORSCH AG: COMPANY OVERVIEW 289
TABLE 269 L.B. BOHLE MASCHINEN UND VERFAHREN GMBH: COMPANY OVERVIEW 290
TABLE 270 LFA MACHINES: COMPANY OVERVIEW 291
TABLE 271 CVC TECHNOLOGIES, INC.: COMPANY OVERVIEW 292
TABLE 272 OHARA TECHNOLOGIES: COMPANY OVERVIEW 293
TABLE 273 PRISM PHARMA MACHINERY: COMPANY OVERVIEW 294
TABLE 274 SAINTYCO: COMPANY OVERVIEW 295
TABLE 275 SILVERSON: COMPANY OVERVIEW 296
TABLE 276 YENCHEN MACHINERY CO., LTD.: COMPANY OVERVIEW 297
TABLE 277 QUALICAPS: COMPANY OVERVIEW 298
TABLE 278 COESIA S.P.A.: COMPANY OVERVIEW 299
TABLE 279 UHLMANN: COMPANY OVERVIEW 300
TABLE 280 AST, LLC: COMPANY OVERVIEW 301
TABLE 281 MAJOR SECONDARY SOURCES 304
TABLE 282 PRIMARY INTERVIEW PARTICIPANTS 305
TABLE 283 DATA CAPTURED FROM PRIMARY SOURCES 306
TABLE 284 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RISK ANALYSIS 313

FIGURE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SEGMENTATION AND REGIONAL SCOPE 31
FIGURE 2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DURATION COVERED 32
FIGURE 3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SCENARIO 35
FIGURE 4 GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE,
2021-2032 36
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, JANUARY 2022-JANUARY 2026 36
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 37
FIGURE 7 HIGH-GROWTH SEGMENTS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, 2026-2032 38
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD 39
FIGURE 9 HIGH EMPHASIS ON AUTOMATING PRODUCTION AND IMPROVING THROUGHPUT TO DRIVE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 40
FIGURE 10 PACKAGING MACHINES SEGMENT TO CAPTURE LARGEST MARKET SHARE
IN 2026 AND 2032 41
FIGURE 11 LIQUID SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2032 41
FIGURE 12 AUTOMATIC TECHNOLOGY TO DOMINATE MARKET SHARE FROM 2026 TO 2032 42
FIGURE 13 PACKAGING MACHINES SEGMENT AND US TO HOLD LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
IN NORTH AMERICA IN 2032 42
FIGURE 14 INDIA TO BE FASTEST-GROWING MARKET FOR PHARMACEUTICAL MANUFACTURING EQUIPMENT DURING FORECAST PERIOD 43
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44
FIGURE 16 IMPACT ANALYSIS: DRIVERS 47
FIGURE 17 IMPACT ANALYSIS: RESTRAINTS 49
FIGURE 18 IMPACT ANALYSIS: OPPORTUNITIES 51
FIGURE 19 IMPACT ANALYSIS: CHALLENGES 53
FIGURE 20 PORTER'S FIVE FORCES ANALYSIS 58
FIGURE 21 PHARMACEUTICAL MANUFACTURING EQUIPMENT VALUE CHAIN ANALYSIS 64
FIGURE 22 PHARMACEUTICAL MANUFACTURING EQUIPMENT ECOSYSTEM 66
FIGURE 23 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2022-2025 69
FIGURE 24 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES,
BY REGION, 2022-2025 70
FIGURE 25 INVESTMENT AND FUNDING SCENARIO, 2020-2024 71
FIGURE 26 IMPORT SCENARIO FOR HS CODE 8479-COMPLIANT PRODUCTS IN TOP FIVE COUNTRIES, 2021-2025 72
FIGURE 27 EXPORT SCENARIO FOR HS CODE 8479-COMPLIANT PRODUCTS IN TOP FIVE COUNTRIES, 2021-2025 73
FIGURE 28 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 74
FIGURE 29 PATENT APPLIED AND GRANTED, 2016-2025 93
FIGURE 30 DECISION-MAKING FACTORS CONSIDERED WHILE BUYING PHARMACEUTICAL MANUFACTURING EQUIPMENT 105
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-PRODUCT TYPE 106
FIGURE 32 KEY BUYING CRITERIA, BY END-PRODUCT TYPE 107
FIGURE 33 PHARMACEUTICAL MANUFACTURING EQUIPMENT ADOPTION BARRIERS AND INTERNAL CHALLENGES 108
FIGURE 34 PHARMACEUTICAL MANUFACTURING EQUIPMENT END USERS 111
FIGURE 35 MAJOR PHARMACEUTICAL EQUIPMENT MANUFACTURING PROCESSES 113
FIGURE 36 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 117
FIGURE 37 PACKAGING MACHINES SEGMENT TO DOMINATE MARKET FROM 2026 TO 2032 117
FIGURE 38 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET,
BY END-PRODUCT TYPE 169
FIGURE 39 SOLID SEGMENT TO ACCOUNT FOR LARGER SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN 2026 169
FIGURE 40 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY 173
FIGURE 41 AUTOMATIC SEGMENT TO CAPTURE LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN 2026 173
FIGURE 42 ASIA PACIFIC TO EXHIBIT HIGHEST CAGR BETWEEN 2026 AND 2032 177
FIGURE 43 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT
MARKET SNAPSHOT 179
FIGURE 44 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT 188
FIGURE 45 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT
MARKET SNAPSHOT 199
FIGURE 46 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
REVENUE ANALYSIS OF TOP PLAYER, 2020-2024 224
FIGURE 47 MARKET SHARE ANALYSIS OF COMPANIES OFFERING
PHARMACEUTICAL MANUFACTURING EQUIPMENT, 2025 225
FIGURE 48 COMPANY VALUATION 227
FIGURE 49 FINANCIAL METRICS (EV/EBITDA) 227
FIGURE 50 BRAND COMPARISON 228
FIGURE 51 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY COMPANIES), 2025 229
FIGURE 52 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY FOOTPRINT 230
FIGURE 53 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 235
FIGURE 54 GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT 252
FIGURE 55 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 272
FIGURE 56 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH DESIGN 302
FIGURE 57 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH APPROACH 303
FIGURE 58 DATA CAPTURED FROM SECONDARY SOURCES 304
FIGURE 59 CORE FINDINGS FROM INDUSTRY EXPERTS 306
FIGURE 60 BREAKDOWN OF PRIMARY INTERVIEW, BY COMPANY TYPE,
DESIGNATION, AND REGION 307
FIGURE 61 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
BOTTOM-UP APPROACH 308
FIGURE 62 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: TOP-DOWN APPROACH 308
FIGURE 63 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE ESTIMATION (SUPPLY SIDE) 309
FIGURE 64 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: FACTOR ANALYSIS 310
FIGURE 65 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DATA TRIANGULATION 311
FIGURE 66 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
RESEARCH ASSUMPTIONS 312
FIGURE 67 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET:
INSIGHTS FROM INDUSTRY EXPERTS 314